MRC Cancer Unit
Oncology, Biomarkers, Oesophagus, Early Detection, Risk Stratification
As a molecular biologist, I am interested in the processes that can detect disease.
In particular, oesophageal cancer has one of the worst survival rates. This is mostly due to the late diagnosis, because when patients start exhibiting symptoms the cancer is very advanced. We now know that cancer is easier to cure when it is detected early. That is why we are trying to find detection tools for early signs of oesophageal cancer or to detect patients that are at risk of developing it in the near future.
The Lab I work in has developed the Cytosponge, which is a safe and effective tool to monitor patients before cancer appears. These patients can then go on to have less invasive surgeries than what they would need if the cancer had been detected later, giving them longer survival times. We are extremely fortunate to be located in Cambridge Biomedical Campus, where we have a multidisciplinary team as well as very collaborative patients, that are willing to participate in our research projects.